21/xsl/MobileMenu.xsltmobileNave880e1541/WorkArea//https://www.rsna.org/TwoColumnWireframe.aspx?pageid=3812&ekfxmen_noscript=1&ekfxmensel=falsefalsetruetruetruefalsefalse10-18.0.0.0730truefalse
  •  
     
    • QIBA Processes

    • The QIBA Process to Achieve Standards-based Quantitative Imaging Biomarkers

      Optimal patient care, clinical research and new therapy development require efficient and valid methods to quantify the results of biomedical imaging. QIBA accelerates the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.

      Stakeholders from the clinical research community, imaging equipment manufacturers, the pharmaceutical industry, government and medical informatics companies collaborate through QIBA to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.

      The Three Steps of the QIBA Process

      1.   Define the clinical question and proposed biomarker to be addressed. 
      2.   Production of Protocol and Profile
      3. Profile Validation, Promulgation and Maintenance  

        For more process details please see the full Description of QIBA Process.
       

      The QIBA Approach

      QIBA follows a defined, coordinated process for solutions development and adoption.

      1.   Identify Sources of Error and Variation in Quantitative Results from Imaging Methods. Stakeholders work to identify problems leading to error or variability in quantitative results from imaging methods.
      2.   Specify Potential Solutions. Stakeholders identify potential strategies and infrastructure for error mitigation and collaborate on development of hardware, software, and protocol solutions, documenting them in the form of QIBA profiles.
      3.   Test Solutions. Vendors and researchers implement QIBA solutions to assess their feasibility and efficacy.
      4.   Promulgate Solutions. Validated solutions are disseminated and implemented through vendor adoption, research integration and clinical education.

      For more information, please see the QIBA Fact Sheet for reference.
       

    We appreciate your comments and suggestions in our effort to improve your RSNA web experience.

    Name (required)

     

    Email Address (required)

     

    Comments (required)

     

     

     

     

    Discounted Dues: Eligible North American Countries 
    Belize
    Costa Rica
    Dominican Republic
    El Salvador
    Grenada
    Guatamala
    Haiti
    Honduras
    Jamaica
    Netherlands Antilles
    Nicaragua
    Panama
    St.Lucia
    St. Vincent & Grenadines
    Country    Country    Country 
    Afghanistan   Grenada   Pakistan
    Albania   Guatemala   Papua New Guinea
    Algeria   Guinea   Paraguay
    Angola   Guinea-Bissau   Peru
    Armenia   Guyana   Phillippines
    Azerbaijan   Haiti   Rwanda
    Bangladesh   Honduras   Samoa
    Belarus   India   Sao Tome & Principe
    Belize   Indonesia   Senegal
    Benin   Iran   Serbia
    Bhutan   Iraq   Sierra Leone
    Bolivia   Jordan   Solomon Islands
    Bosnia & Herzegovina   Jamaica   Somalia
    Botswana   Kenya   South Africa
    Bulgaria   Kiribati   South Sudan
    Burkina Faso   Korea, Dem Rep (North)   Sri Lanka
    Burundi   Kosovo   St Lucia
    Cambodia   Kyrgyzstan   St Vincent & Grenadines
    Cameroon   Laos\Lao PDR   Sudan
    Cape Verde   Lesotho   Swaziland
    Central African Republic   Liberia   Syria
    Chad   Macedonia   Tajikistan
    China   Madagascar   Tanzania
    Colombia   Malawi   Thailand
    Comoros   Maldives   Timor-Leste
    Congo, Dem. Rep.   Mali   Togo
    Congo, Republic of   Marshall Islands   Tonga
    Cote d'Ivoire   Mauritania   Tunisia
    Djibouti   Micronesia, Fed. Sts.   Turkmenistan
    Dominica   Moldova   Tuvalu
    Domicican Republic   Mongolia   Uganda
    Ecuador   Montenegro   Ukraine
    Egypt   Morocco   Uzbekistan
    El Salvador   Mozambique   Vanuatu
    Eritrea   Myanmar   Vietnam
    Ethiopia   Namibia   West Bank & Gaza
    Fiji   Nepal   Yemen
    Gambia, The   Nicaragua   Zambia
    Georgia   Niger   Zimbabwe
    Ghana   Nigeria    

    Legacy Collection 2
    Radiology Logo
    RadioGraphics Logo 
    Tier 1

    • Bed count: 1-400
    • Associate College: Community, Technical, Further Education (UK), Tribal College
    • Community Public Library (small scale): general reference public library, museum, non-profit administration office

    Tier 2

    • Bed count: 401-750
    • Baccalaureate College or University: Bachelor's is the highest degree offered
    • Master's College or University: Master's is the highest degree offered
    • Special Focus Institution: theological seminaries, Bible colleges, engineering, technological, business, management, art, music, design, law

    Tier 3

    • Bedcount: 751-1,000
    • Research University: high or very high research activity without affiliated medical school
    • Health Profession School: non-medical, but health focused

    Tier 4

    • Bed count: 1,001 +
    • Medical School: research universities with medical school, including medical centers

    Tier 5

    • Consortia: academic, medical libraries, affiliated hospitals, regional libraries and other networks
    • Corporate
    • Government Agency and Ministry
    • Hospital System
    • Private Practice
    • Research Institute: government and non-government health research
    • State or National Public Library
    • Professional Society: trade unions, industry trade association, lobbying organization